Prediction of Antidepressant Treatment Response Using Machine Learning Classification Analysis

NCT02330679 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

61

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Desvenlafaxine
DRUG: Placebo

Sponsor

University of Calgary

Collaborators

[object Object]